Advertisement

Schilddrüsenfunktionsstörungen in der Reproduktionsmedizin

  • Catharina Bullmann
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Die physiologischen Veränderungen der Schilddrüsenfunktion in der Schwangerschaft werden dargestellt. Schilddrüsenfunktionsstörungen sind bei jungen Frauen im reproduktiven Alter häufig. Einflüsse von Schilddrüsenfunktionsstörungen auf die Reproduktivität sind teils gut belegt, teils wahrscheinlich. Die speziellen Indikationen für eine Schilddrüsenhormonbehandlung bei Kinderwunsch und Schwangerschaft, einschließlich der trimenonspezifischen Referenzbereiche, werden dargestellt und konkrete Empfehlungen zur praktischen Durchführung gegeben. Neben der Hypothyreose werden die Differenzialdiagnose der Hyperthyreose und die therapeutischen Implikationen in dieser speziellen Lebensphase erläutert.

Literatur

  1. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A (2007) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92(8):S1–S47CrossRefPubMedGoogle Scholar
  2. Alexander EK, Pearce EN, Brent GA, Brown RS, CHen H, Dosiou C, Broman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S (2017) 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27:315–389CrossRefPubMedGoogle Scholar
  3. Andersen SL, Andersen S, Liew Z, Vestergaard P, Olsen J (2018) Maternal thyroid function in early pregnancy and neuropsychological performance of the child at 5 years of age. J Clin Endocrinol Metab 103:660–670CrossRefPubMedGoogle Scholar
  4. Chan GW, Mandel SJ (2007) Therapy insight: management of Graves’ disease during pregnancy. Nat Clin Pract Endocrinol Metab 3:470–478CrossRefPubMedGoogle Scholar
  5. Cooper DS, Rivkees SA (2009) Putting propylthiouracil in perspective. J Clin Endocrinol Metab 94:1881–1882CrossRefPubMedGoogle Scholar
  6. Glinoer D (1997) The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18:404–433CrossRefPubMedGoogle Scholar
  7. Glinoer D, Abalovic M (2007) Unresolved questions in managing hypothyreoidism during pregnancy. BMJ 11:300–302CrossRefGoogle Scholar
  8. Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Baidya B (2014) 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy an in children. Eu Thyroid J 3:76–94CrossRefGoogle Scholar
  9. Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, Bloigu A, Järvelin MR, Suvanto-Luukkonen E (2009) Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 94:772–779CrossRefPubMedGoogle Scholar
  10. Nazarpour S, Tehrani FR, Simbar M, Tohidi M, Majd HA, Azizi F (2017) Effects of levothyroxine treatment on pregnancy outcomes in regnant women with autoimmunge thyroid disease. Eur J Endocrinol 176:253–265CrossRefPubMedGoogle Scholar
  11. Nazarpour S, Tehrani FR, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F (2018) Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrinol Metab 103:926–935CrossRefPubMedGoogle Scholar
  12. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R, Locorotondo G, Caroli P, Pezzarossa A, Dazzi D, Hassan H (2005) Levothyroxine treatment in thyroid peroxidase antibodypositive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 20:1529–1533CrossRefPubMedGoogle Scholar
  13. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H (2006) Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstretical complications. J Clin Endocrinol Metab 91:2587–2591CrossRefPubMedGoogle Scholar
  14. Plowden TC, Schisterman EF, LA SJ, Zaren SM, Perkins NJ, Silver R, Glas N, AH DC, Mumford SL (2016) Subclinical hypothyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss, for live birth. J Clin Endocrine Metab 101:2358–2365CrossRefGoogle Scholar
  15. Poppe K, Velkeniers B, Glinoer D (2007) Thyroid disease an female reproduction. Clin Endocrinol 66:309–321CrossRefGoogle Scholar
  16. Poppe K, Velkeniers B, Glinoer D (2008) The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 4:394–405CrossRefPubMedGoogle Scholar
  17. Refetoff S, Weiss SE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14(3):348–399PubMedGoogle Scholar
  18. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A (2011) Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 342:d2616CrossRefPubMedPubMedCentralGoogle Scholar
  19. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: The Wickham survey. Clin Endocrinol 7:481–493CrossRefGoogle Scholar
  20. Wang C, Crapo LM (1997) The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin N Am 26:189–218CrossRefGoogle Scholar
  21. Wiersinga WM, Bartalena L (2002) Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid 12(10):855–860CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Zentrum für Endokrinologie, Kinderwunsch und Pränatale Medizin im BarkhofamedesHamburgDeutschland

Personalised recommendations